Agenus Inc (AGEN): Capital Expenditures
$6.0K
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
-95.2%
3-year compound annual growth
-72.0%
5-year compound annual growth
-47.2%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.0K | -99.0% | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | $576.0K | -94.2% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | $9.95M | -81.2% | 2026-03-16, From 2023-01-01 |
| 2022-12-31 | $53.06M | +56.9% | 2025-03-17, From 2022-01-01 |
| 2021-12-31 | $33.81M | +875.6% | 2024-03-14, From 2021-01-01 |
| 2020-12-31 | $3.47M | -25.6% | 2023-03-16, From 2020-01-01 |
| 2019-12-31 | $4.66M | +29.5% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $3.60M | +15.3% | 2021-03-16, From 2018-01-01 |
| 2017-12-31 | $3.12M | -75.1% | 2020-03-16, From 2017-01-01 |
| 2016-12-31 | $12.52M | +248.6% | 2019-03-18, From 2016-01-01 |
| 2015-12-31 | $3.59M | +27.4% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $2.82M | +246.6% | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $813.5K | +686.5% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $103.4K | +89.6% | 2015-03-16, From 2012-01-01 |
| 2011-12-31 | $54.5K | -58.2% | 2014-03-07, From 2011-01-01 |
| 2010-12-31 | $130.4K | -46.5% | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $243.9K | n/a | 2012-03-06, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Agenus Inc (AGEN) | 2025-12-31 | $6.0K | -99.0% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $3.85M | -44.2% |
| Century Therapeutics, Inc. (IPSC) | 2025-12-31 | $848.0K | +450.6% |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $0 | -100.0% |
| Monte Rosa Therapeutics, Inc. (GLUE) | 2025-12-31 | $4.70M | +17.9% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $14.95M | +67.1% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $536.0K | -85.8% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $3.83M | -22.8% |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 2025-12-31 | $7.67M | -87.7% |
Compare AGEN, IBRX, IPSC, ATRA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗